跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retaclav-R - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retaclav-R
Approved
STANDARD
Retaclav-R
Indchemie Health Specialities Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ecd54b11cfa0ee6d
Company
Indchemie Health Specialities Private Limited
Type
Standard
Approval Details
Approval Id
ecd54b11cfa0ee6d
Drug Approval Philippines Name
Retaclav-R
Product Name
Retaclav-R
Registration Number
DRP-1092-13
Brand Name
Retaclav-R
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Suspension
Dosage Strength
312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL
Manufacturer
Indchemie Health Specialities Private Limited
Importer
Suhitas Pharmaceuticals Inc.
Distributor
Reta Drug
Issuance Date
24 June 2024
Expiry Date
14 October 2028
Pharmacologic Category
Antibacterial (Penicillin + Beta- Lactamase Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ecd54b11cfa0ee6d
Type
Standard
Back to Philippines FDA Approvals